The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 55 | — | 20.1x | Near average | |
Growth | 18 | -14.0% | 5.6% | Below average | |
Quality | 40 | -21.3% | 7.6% | Near average | |
Safety | 19 | 4.4x | 0.4x | Below average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
RxSight, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy RxSight, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Data indicates a state of divergence in analyst coverage for RxSight; while the average price target remained stable at 10.25 dollars (representing a price premium of approximately 95% over the current price), the number of active analysts providing updated estimates decreased from 5 to only 2 during the past week. This contraction in the analyst base increases uncertainty regarding the general consensus, despite the target price range remaining between 9 and 11 dollars.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.